Article Text

AB0122 Regulatory t cell abnormalities and il-2 deficiency in patients with systemic lupus erythematosus
  1. C. von Spee-Mayer1,2,
  2. N. Wassermann2,
  3. A. Rose1,2,
  4. T. Alexander1,2,
  5. J. Klocke2,
  6. J. Y. Humrich1,2,
  7. G. Riemekasten1,2
  1. 1German Rheumatism Research Center (DRFZ)
  2. 2Rheumatology And Clinical Immunology, CHARITÉ - University Hospital, Berlin, Germany


Background Quantitative and qualitative aberrations of CD4+ Foxp3+ regulatory T cells (Treg) have been associated with systemic lupus erythematosus (SLE). In addition, impaired production of IL-2 by T cells has been described in patients with SLE.

Objectives Here, we aim to substantiate the link between IL-2 deficiency and Treg abnormalities in SLE.

Methods Phenotype, frequency and homeostatic proliferation of CD4+Foxp3+CD127lo Treg and CD4+Foxp3- conventional T cell (Tcon) subsets were analyzed by multi-color flow-cytometry in PBMCs from SLE patients and healthy donors ex vivo and after in vitro stimulation with varying doses of human IL-2 (Proleukin). IL-2 mRNA expression of CD4+ T cells in vitro was determined by real-time PCR. Disease activity was determined according to the SLE activity index (SLEDAI).

Results The expression of CD25 in Foxp3+CD127lo Treg was significantly reduced in SLE patients compared to healthy donors. Proliferation of Tcon was significantly increased in SLE patients, resulting in a reduced Treg to Tcon proliferation ratio, which inversely correlated with disease activity. In contrast, the Treg to Tcon proliferation ratio positively correlated with the frequency of CD25+ Treg and with the in vitro IL-2 mRNA expression of CD4+ T cells. Spontaneous in vitro IL-2 mRNA expression of CD4+ T cells was significantly reduced in SLE patients compared to healthy controls.

IL-2 stimulation of SLE PBMCs in vitro significantly augmented CD25 expression levels in Treg. The frequency of CD25high cells among Treg was most efficiently increased when the lowest dose of 1ng/ml IL-2 was applied. In parallel, IL-2 stimulation significantly amplified the expression of anti-apoptotic Bcl-2 in SLE Treg.

Conclusions In analogy to our previous findings in lupus-prone mice (1), Treg from SLE patients show the classical hallmarks of IL-2 deficiency with loss of CD25 expression and a homeostatic imbalance between Treg and Tcon. These findings could be associated with a reduced IL-2 expression by CD4+ T cells in SLE patients. On the other hand, lowdose IL-2 stimulation in vitro could restore these defects, underlying the potential of IL-2 as a novel therapeutic option in SLE.

  1. Humrich, JY et al, PNAS, 2010

Disclosure of Interest None Declared

Statistics from

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.